Type I and type II interferons have overlapping and distinct functions in the host immune response to cancer. In this article, recent data that link interferons to the process of cancer immunoediting are reviewed, and possible therapeutic applications are considered.
- Gavin P. Dunn
- Catherine M. Koebel
- Robert D. Schreiber